Cardiovscular Cell Therapy Research Network (CCTRN) is sponsored and funded by the National Heart, Lung, and Blood Institute (NHLBI), which is one of 27 institutes/centers of the National Institutes of Health (NIH) and provides global leadership for a research, training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.